Natural Product: NPC599840| Natural Product ID | NPC599840 |
|
Common Name
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
| OBKXEAXTFZPCHS-UHFFFAOYSA-N |
| IUPAC Name | n.a. |
| Synonyms | |
| Synthetic Gene Cluster | n.a. |
| ChEMBL Identifier | CHEMBL1469 |
| PubChem CID | n.a. |
| Chemical Classification |
|
The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.
Chemical Representations
| Standard InCHIKey | OBKXEAXTFZPCHS-UHFFFAOYSA-N |
| Standard InCHI | InChI=1S/C10H12O2/c11-10(12)8-4-7-9-5-2-1-3-6-9/h1-3,5-6H,4,7-8H2,(H,11,12) |
| SMILES | O=C(O)CCCc1ccccc1 |
  Calculated Properties| Molecular Weight:   | 164.08 | Volume:   | 179.994 Van der Waals volume.
|
| Dense:   | 0.912 | LogP:   | 2.293 The logarithm of the n-octanol/water distribution coefficients.
|
| logD7.4:   | 1.894 The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
|
LogS:   | -1.911 The logarithm of aqueous solubility value.
|
| Rotatable Bonds:   | 4.0 | Rigid Bonds:   | 7.0 |
| TPSA:   | 37.3 Topological Polar Surface Area.
|
H-Bond Acceptor:   | 2.0 |
| H-Bond Donor:   | 1.0 | Rings:   | 1.0 |
| Heavy Atoms:   | 2.0 |
| QED Drug-Likeness Score:   | 0.739 | GASA:   | 0.0 GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
|
| Synthetic Accessibility Score:   | 1.293 | Fsp3:   | 0.3 |
| MCE-18:   | 5.0 MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
|
Lipinski Rule-of-5:   | Rejected |
| Pfizer Rule:   | Rejected | GSK Rule:   | Rejected |
| Golden Triangle Rule:   | Accepted | BMS Rule:   | 0 |
| Chelating Alert:   | 0 | PAINS Alert:   | 0 |
| Colloidal aggregators:   | 0.002 | Fluc inhibitor:   | 0.001 The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
|
| Blue fluorescence:   | 0.051 The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
|
Green fluorescence:   | 0.044 The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
|
| Reactive compounds:   | 0.963 | Promiscuous compounds:   | 0.432 |
| Caco-2 Permeability:   | -4.67 | MDCK Permeability:   | -4.529 |
| Pgp-inhibitor:   | 0.006 | Pgp-substrate:   | 0.024 |
| PAMPA:   |
0.978 The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
|
Human Intestinal Absorption (HIA):   | 0.069 |
| 20% Bioavailability (F20%):   | 0.007 | 30% Bioavailability (F30%):   | 0.033 |
| 50% Bioavailability (F50%):   | 0.011 |
| Blood-Brain-Barrier Penetration (BBB):   | 0.244 | MRP1:   | 0.713 |
| Plasma Protein Binding (PPB):   | 96.718% | Volume Distribution (VD):   | -0.754 |
| Fu: |
3.219% The fraction unbound in plasms.
|
OATP1B1 inhibitor:   | 0.454 |
| OATP1B3 inhibitor:   | 0.776 | BCRP inhibitor:   | 0.011 |
| BSEP inhibitor:   | 0.566 |
| CYP1A2-inhibitor:   | 0.101 | CYP1A2-substrate:   | 0.0 |
| CYP2C19-inhibitor:   | 0.012 | CYP2C19-substrate:   | 0.003 |
| CYP2C9-inhibitor:   | 0.998 | CYP2C9-substrate:   | 0.001 |
| CYP2D6-inhibitor:   | 0.01 | CYP2D6-substrate:   | 0.0 |
| CYP3A4-inhibitor:   | 0.017 | CYP3A4-substrate:   | 0.005 |
| CYP2B6-substrate:   | 0.943 | CYP2C8-inhibitor:   | 0.104 |
| HLM stability:   |
0.003 Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.
|
| Clearance (CL):   | 6.331 | Half-life (T1/2):   | 1.011 |
| hERG Blockers:   | 0.106 | hERG Blockers (10um):   | 0.261 |
| Human Hepatotoxicity (H-HT):   | 0.483 | Drug-induced Liver Injury (DILI):   | 0.228 |
| AMES Toxicity:   | 0.236 | Rat Oral Acute Toxicity:   | 0.14 |
| Maximum Recommended Daily Dose:   | 0.254 | Skin Sensitization:   | 0.593 |
| Carcinogencity:   | 0.296 | Eye Corrosion:   | 0.708 |
| Eye Irritation:   | 0.99 | Respiratory Toxicity:   | 0.428 |
| Drug-induced Neurotoxicity:   | 0.308 | Ototoxicity:   | 0.437 |
| Hematotoxicity:   | 0.412 | Drug-induced Nephrotoxicity:   | 0.608 |
| Genotoxicity:   | 0.041 | RPMI-8226 Immunitoxicity:   | 0.026 |
| A549 Cytotoxicity:   | 0.016 | Hek293 Cytotoxicity:   | 0.06 |
| BCF:   |
0.201 Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
|
IGC50:   |
2.852 48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
|
| LC50DM:   |
3.803 48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
|
LC50FM:   |
3.179 96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].
|
  Species Source| Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
|---|---|---|---|---|---|---|---|---|
| NPO49406 | Streptomyces sp. Al-Dhabi-97 | Genus | Streptomycetaceae | Bacteria | n.a. | n.a. | n.a. | Database[COCONUT] |
Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
  NP Quantity Composition/Concentration| Organism ID | Organism Name | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
|---|
Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Biological Activity
| Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
|---|---|---|---|---|---|---|---|---|
| NPT224 | Individual protein | Alpha-2c adrenergic receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT291 | Individual protein | Serotonin 2b (5-HT2b) receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT1410 | Individual protein | GABA receptor alpha-1 subunit | Rattus norvegicus | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT228 | Individual protein | Norepinephrine transporter | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT1788 | Individual protein | Alpha-1a adrenergic receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT282 | Individual protein | MAP kinase ERK2 | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
| NPT222 | Individual protein | Alpha-2a adrenergic receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT232 | Individual protein | Cannabinoid CB1 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT263 | Individual protein | Muscarinic acetylcholine receptor M2 | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT230 | Individual protein | Bradykinin B2 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT1464 | Individual protein | Phosphodiesterase 4D | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT222 | Individual protein | Alpha-2a adrenergic receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT242 | Individual protein | Dopamine D1 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT244 | Individual protein | Dopamine D3 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT297 | Individual protein | Neurokinin 1 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT290 | Individual protein | Serotonin 2a (5-HT2a) receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT252 | Individual protein | Histamine H2 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT218 | Individual protein | Adenosine A3 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT239 | Individual protein | Cholecystokinin A receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT303 | Individual protein | Vasopressin V1a receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT259 | Individual protein | Melanocortin receptor 4 | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT261 | Individual protein | Monoamine oxidase A | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT252 | Individual protein | Histamine H2 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT1858 | Individual protein | Dopamine D2 receptor | Rattus norvegicus | Ki | n.a. | n.a. | n.a. | PMID[21055848] |
| NPT1163 | Individual protein | Glutamate (NMDA) receptor subunit zeta 1 | Rattus norvegicus | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT266 | Individual protein | Muscarinic acetylcholine receptor M5 | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT3056 | Individual protein | Dopamine D3 receptor | Rattus norvegicus | Ki | n.a. | n.a. | n.a. | PMID[21055848] |
| NPT1070 | Individual protein | Sigma-1 receptor | Cavia porcellus | Ki | > | 10000.0 | nM | PMID[21055848] |
| NPT248 | Individual protein | Estrogen receptor beta | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT1788 | Individual protein | Alpha-1a adrenergic receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT1788 | Individual protein | Alpha-1a adrenergic receptor | Homo sapiens | AC50 | = | 14041.7 | nM | PMID[37468498] |
| NPT232 | Individual protein | Cannabinoid CB1 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT1785 | Individual protein | Serotonin 7 (5-HT7) receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT243 | Individual protein | Dopamine D2 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT2879 | Individual protein | Equilibrative nucleoside transporter 1 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT2769 | Individual protein | Thromboxane A2 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT216 | Individual protein | Adenosine A1 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT223 | Individual protein | Alpha-2b adrenergic receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT242 | Individual protein | Dopamine D1 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT1407 | Individual protein | GABA-B receptor 1 | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT251 | Individual protein | Histamine H1 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT291 | Individual protein | Serotonin 2b (5-HT2b) receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT249 | Individual protein | Glucocorticoid receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT264 | Individual protein | Muscarinic acetylcholine receptor M3 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT299 | Individual protein | Androgen Receptor | Rattus norvegicus | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT295 | Individual protein | Serotonin transporter | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT263 | Individual protein | Muscarinic acetylcholine receptor M2 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT294 | Individual protein | Serotonin 6 (5-HT6) receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT262 | Individual protein | Muscarinic acetylcholine receptor M1 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT267 | Individual protein | Neuropeptide Y receptor type 1 | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT217 | Individual protein | Adenosine A2a receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT108 | Individual protein | Estrogen receptor alpha | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT2719 | Individual protein | Voltage-gated L-type calcium channel alpha-1C subunit | Rattus norvegicus | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT298 | Individual protein | Neurokinin 2 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT246 | Individual protein | Dopamine transporter | Homo sapiens | AC50 | = | 3200.0 | nM | PMID[37468498] |
| NPT31 | Individual protein | Cyclooxygenase-2 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT247 | Individual protein | Endothelin receptor ET-A | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT1647 | Individual protein | Vasopressin V2 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT1814 | Individual protein | Glucagon receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT265 | Individual protein | Muscarinic acetylcholine receptor M4 | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT290 | Individual protein | Serotonin 2a (5-HT2a) receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT292 | Individual protein | Serotonin 2c (5-HT2c) receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT245 | Individual protein | Dopamine D4 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT686 | Individual protein | Histone deacetylase 3 | Homo sapiens | IC50 | = | 260000.0 | nM | PMID[21874153] |
| NPT707 | Individual protein | NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens | IC50 | > | 100000.0 | nM | PMID[22583019] |
| NPT5318 | Individual protein | Corticotropin releasing factor receptor 1 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT689 | Individual protein | Histone deacetylase 5 | Homo sapiens | IC50 | > | 2000000.0 | nM | PMID[21874153] |
| NPT72 | Individual protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 71.09 | % | PMID[23571415] |
| NPT30134 | Single protein | Gastric inhibitory polypeptide receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT713 | Individual protein | Bile salt export pump | Homo sapiens | FC | = | 3.0 | n.a. | PMID[22464344] |
| NPT5301 | Individual protein | Motilin receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT987 | Individual protein | Histamine H3 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT684 | Individual protein | Histone deacetylase 1 | Homo sapiens | IC50 | = | 64000.0 | nM | PMID[21874153] |
| NPT73 | Individual protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 62.24 | % | PMID[23571415] |
| NPT4358 | Individual protein | Type-1 angiotensin II receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT692 | Individual protein | Histone deacetylase 6 | Homo sapiens | Inhibition | n.a. | n.a. | % | PMID[21874153] |
| NPT542 | Individual protein | Progesterone receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT3735 | Individual protein | Neurotensin receptor 1 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT692 | Individual protein | Histone deacetylase 6 | Homo sapiens | IC50 | = | 240000.0 | nM | PMID[21874153] |
| NPT685 | Individual protein | Histone deacetylase 2 | Homo sapiens | IC50 | = | 65000.0 | nM | PMID[21874153] |
| NPT688 | Individual protein | Histone deacetylase 4 | Homo sapiens | IC50 | > | 2000000.0 | nM | PMID[21874153] |
| NPT20556 | Single protein | Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | 20.4 | % | Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen |
| NPT692 | Individual protein | Histone deacetylase 6 | Homo sapiens | Inhibition | = | 15.31 | % | HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators |
| NPT29430 | Single protein | Neuronal acetylcholine receptor protein alpha-4 subunit | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT692 | Individual protein | Histone deacetylase 6 | Homo sapiens | Inhibition | = | -4.8 | % | HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators |
| NPT98 | Individual protein | HERG | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT22587 | Single protein | Taste receptor type 2 member 39 | Homo sapiens | Inhibition | = | 40.0 | % | EP-2323502-B1 |
| NPT4729 | Individual protein | Cholecystokinin B receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT691 | Individual protein | Histone deacetylase 9 | Homo sapiens | IC50 | > | 2000000.0 | nM | PMID[21874153] |
| NPT690 | Individual protein | Histone deacetylase 7 | Homo sapiens | IC50 | > | 2000000.0 | nM | PMID[21874153] |
| NPT3952 | Individual protein | Endothelin receptor ET-B | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT93 | Individual protein | Survival motor neuron protein | Homo sapiens | Potency | = | 1122.0 | nM | PubChem BioAssay data set |
| NPT5975 | Individual protein | Cyclooxygenase-1 | Rattus norvegicus | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT591 | Individual protein | Glycogen synthase kinase-3 beta | Homo sapiens | Inhibition | = | 125.6 | % | PMID[17566732] |
| NPT92 | Individual protein | Serotonin 1a (5-HT1a) receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT28787 | Single protein | Voltage-gated N-type calcium channel alpha-1B subunit | Rattus norvegicus | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT5104 | Individual protein | Phosphodiesterase 3A | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT28814 | Single protein | Ghrelin receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT20859 | Single protein | Neuropeptide Y receptor type 2 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT92 | Individual protein | Serotonin 1a (5-HT1a) receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT28448 | Single protein | Corticotropin releasing factor receptor 2 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT6127 | Individual protein | Bradykinin B1 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT30151 | Single protein | Melanocortin receptor 3 | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT687 | Individual protein | Histone deacetylase 8 | Homo sapiens | IC50 | = | 93000.0 | nM | PMID[21874153] |
| NPT5666 | Individual protein | Histone deacetylase 6 | Mus musculus | Inhibition | n.a. | n.a. | % | PMID[21874153] |
| NPT49 | Individual protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | n.a. | 1062.1 | nM | PubChem BioAssay data set |
| NPT425 | Individual protein | Serotonin 3a (5-HT3a) receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
|---|---|---|---|---|---|---|---|---|
| NPT406 | Cell line | RXF 393 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT1083 | Cell line | A-375 | Homo sapiens | Activity | = | 87.33 | % | PMID[35818137] |
| NPT1083 | Cell line | A-375 | Homo sapiens | Inhibition | n.a. | n.a. | % | PMID[35818137] |
| NPT367 | Cell line | MDA-N | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT147 | Cell line | SK-MEL-2 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT374 | Cell line | SF-539 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT384 | Cell line | TK-10 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT386 | Cell line | KM12 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT372 | Cell line | HOP-92 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT382 | Cell line | OVCAR-5 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT398 | Cell line | UACC-62 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT394 | Cell line | EKVX | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT387 | Cell line | M14 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT371 | Cell line | UO-31 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT395 | Cell line | SF-268 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT389 | Cell line | RPMI-8226 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT76 | Cell line | C6 | Rattus norvegicus | Activity | n.a. | n.a. | n.a. | PMID[25461306] |
| NPT393 | Cell line | HCT-116 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT380 | Cell line | U-251 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT457 | Cell line | BT-549 | Homo sapiens | GI50 | n.a. | 1000000.0 | nM | PubChem BioAssay data set |
| NPT392 | Cell line | SNB-75 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT306 | Cell line | PC-3 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT81 | Cell line | A549 | Homo sapiens | IC50 | = | 9750000.0 | nM | PMID[35818137] |
| NPT458 | Cell line | IGROV-1 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT90 | Cell line | DU-145 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT378 | Cell line | NCI/ADR-RES | Homo sapiens | GI50 | n.a. | 21183.61 | nM | PubChem BioAssay data set |
| NPT76 | Cell line | C6 | Rattus norvegicus | Activity | = | 20.0 | % | PMID[25461306] |
| NPT519 | Cell line | SH-SY5Y | Homo sapiens | Activity | n.a. | n.a. | n.a. | PMID[24044874] |
| NPT388 | Cell line | NCI-H322M | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT519 | Cell line | SH-SY5Y | Homo sapiens | Activity | n.a. | n.a. | n.a. | PMID[25595686] |
| NPT373 | Cell line | SK-MEL-5 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT370 | Cell line | NCI-H23 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT858 | Cell line | LNCaP | Homo sapiens | IC50 | = | 2324000.0 | nM | PMID[21055848] |
| NPT400 | Cell line | MDA-MB-435 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT402 | Cell line | Hs-578T | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT385 | Cell line | SR | Homo sapiens | GI50 | n.a. | 28510.18 | nM | PubChem BioAssay data set |
| NPT377 | Cell line | OVCAR-3 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT397 | Cell line | NCI-H460 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT399 | Cell line | SF-295 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT308 | Cell line | CAKI-1 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT405 | Cell line | NCI-H226 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT306 | Cell line | PC-3 | Homo sapiens | IC50 | = | 2273000.0 | nM | PMID[21055848] |
| NPT148 | Cell line | HCT-15 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT396 | Cell line | T47D | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT1083 | Cell line | A-375 | Homo sapiens | Activity | = | 7.4 | % | PMID[35818137] |
| NPT391 | Cell line | HCC 2998 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT379 | Cell line | HOP-62 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT323 | Cell line | SW-620 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT82 | Cell line | MDA-MB-231 | Homo sapiens | IC50 | = | 11660000.0 | nM | PMID[35818137] |
| NPT403 | Cell line | UACC-257 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT1083 | Cell line | A-375 | Homo sapiens | Activity | = | 5.38 | % | PMID[35818137] |
| NPT1083 | Cell line | A-375 | Homo sapiens | IC50 | = | 8940000.0 | nM | PMID[35818137] |
| NPT83 | Cell line | MCF7 | Homo sapiens | IC50 | = | 10680000.0 | nM | PMID[35818137] |
| NPT1083 | Cell line | A-375 | Homo sapiens | TGI | = | 10.0 | % | PMID[35818137] |
| NPT112 | Cell line | MOLT-4 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT146 | Cell line | SK-OV-3 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT401 | Cell line | 786-0 | Homo sapiens | GI50 | n.a. | 3388.44 | nM | PubChem BioAssay data set |
| NPT455 | Cell line | NCI-H522 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT111 | Cell line | K562 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT369 | Cell line | ACHN | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT116 | Cell line | HL-60 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT368 | Cell line | SN12C | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT376 | Cell line | A498 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT81 | Cell line | A549 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT82 | Cell line | MDA-MB-231 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT390 | Cell line | LOX IMVI | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT83 | Cell line | MCF7 | Homo sapiens | GI50 | n.a. | 1000000.0 | nM | PubChem BioAssay data set |
| NPT404 | Cell line | CCRF-CEM | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT381 | Cell line | OVCAR-8 | Homo sapiens | GI50 | n.a. | 17338.04 | nM | PubChem BioAssay data set |
| NPT456 | Cell line | OVCAR-4 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT383 | Cell line | SNB-19 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT375 | Cell line | Malme-3M | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT139 | Cell line | HT-29 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT170 | Cell line | SK-MEL-28 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT407 | Cell line | COLO 205 | Homo sapiens | GI50 | n.a. | 100000.0 | nM | PubChem BioAssay data set |
| NPT28438 | Unchecked | Unchecked | n.a. | EC50 | n.a. | n.a. | n.a. | PMID[33848153] |
| NPT20555 | Organism | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | -0.11 | % | Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort |
| NPT20555 | Organism | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 20000.0 | nM | Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity |
| NPT28658 | Protein family | Histone deacetylase | Rattus norvegicus | Activity | = | 14.0 | % | PMID[25461306] |
| NPT28438 | Unchecked | Unchecked | n.a. | Inhibition | n.a. | n.a. | % | PMID[21874153] |
| NPT28438 | Unchecked | Unchecked | n.a. | Potency | = | 819.9 | nM | PubChem BioAssay data set |
| NPT28438 | Unchecked | Unchecked | n.a. | Activity | n.a. | n.a. | n.a. | PMID[33848153] |
| NPT20555 | Organism | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | Hit score | = | 0.1706 | n.a. | Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2 |
| NPT28438 | Unchecked | Unchecked | n.a. | log1/Ki | = | 3.22 | n.a. | PMID[915902] |
| NPT20555 | Organism | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 19952.62 | nM | Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity |
| NPT28438 | Unchecked | Unchecked | n.a. | Potency | n.a. | 16360.1 | nM | PubChem BioAssay data set |
| NPT28833 | No target | No relevant target | n.a. | Activity | n.a. | n.a. | n.a. | PMID[25595686] |
| NPT28438 | Unchecked | Unchecked | n.a. | Activity | n.a. | n.a. | n.a. | PMID[24044874] |
| NPT28438 | Unchecked | Unchecked | n.a. | Ki | > | 10000.0 | nM | PMID[21055848] |
| NPT28658 | Protein family | Histone deacetylase | Rattus norvegicus | Activity | n.a. | n.a. | n.a. | PMID[25461306] |
| NPT28438 | Unchecked | Unchecked | n.a. | Activity | n.a. | n.a. | n.a. | PMID[35818137] |
| NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 6.6 | nM | PubChem BioAssay data set |
| NPT30138 | Protein family | Histone deacetylase | Homo sapiens | Activity | n.a. | n.a. | n.a. | PMID[17566732] |
| NPT173 | Organism | Klebsiella pneumoniae | Klebsiella pneumoniae | Inhibition | = | 14.97 | % | CO-ADD screening of NIH (USA) - Clinical Collection |
| NPT30138 | Protein family | Histone deacetylase | Homo sapiens | Inhibition | n.a. | n.a. | % | PMID[21055848] |
| NPT30138 | Protein family | Histone deacetylase | Homo sapiens | Inhibition | = | 40.0 | % | PMID[21055848] |
| NPT30138 | Protein family | Histone deacetylase | Homo sapiens | Inhibition | n.a. | n.a. | % | PMID[24044874] |
| NPT20 | Organism | Candida albicans | Candida albicans | Inhibition | = | 6.54 | % | CO-ADD screening of NIH (USA) - Clinical Collection |
| NPT28797 | Organism | Cryptococcus neoformans | Cryptococcus neoformans | Inhibition | = | -6.41 | % | CO-ADD screening of NIH (USA) - Clinical Collection |
| NPT30138 | Protein family | Histone deacetylase | Homo sapiens | Ki | = | 2800.0 | nM | PMID[19520580] |
| NPT605 | Organism | Homo sapiens | Homo sapiens | DILI_Concern | n.a. | n.a. | n.a. | PMID[26948801] |
| NPT16 | Organism | Staphylococcus aureus | Staphylococcus aureus | Inhibition | = | 7.47 | % | CO-ADD screening of NIH (USA) - Clinical Collection |
| NPT19 | Organism | Escherichia coli | Escherichia coli | Inhibition | = | 8.43 | % | CO-ADD screening of NIH (USA) - Clinical Collection |
| NPT18 | Organism | Pseudomonas aeruginosa | Pseudomonas aeruginosa | Inhibition | = | 13.63 | % | CO-ADD screening of NIH (USA) - Clinical Collection |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_liver fatty | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_hepatic failure | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_cholecystitis | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_cholelithiasis | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_Combined Scores | = | 1.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_bilirubinemia | = | 1.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_cirrhosis | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_liver function tests abnormal | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_hepatic necrosis | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_hepatomegaly | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_jaundice | = | 0.0 | n.a. | PMID[22194678] |
| NPT747 | Organism | Acinetobacter baumannii | Acinetobacter baumannii | Inhibition | = | 2.48 | % | CO-ADD screening of NIH (USA) - Clinical Collection |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_liver disease | = | 0.0 | n.a. | PMID[22194678] |
| Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
|---|---|---|---|---|---|---|---|---|
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_elevated liver function tests | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_hepatitis | = | 0.0 | n.a. | PMID[22194678] |
Experimental ADME
| Experiment Model | Experiment Tissue | ADME Type | ADME Relation | ADME Value | ADME Unit | Reference |
|---|---|---|---|---|---|---|
| n.a. | n.a. | LogP | = | 2.42 | n.a. | PMID[17300161] |
| Homo sapiens | n.a. | Papp | = | 0.74 | 10^-6 cm/s | PMID[35818137] |
| Homo sapiens | n.a. | Papp | < | 0.48 | 10^-6 cm/s | PMID[35818137] |
| n.a. | n.a. | log Pe | = | 3.87 | n.a. | PMID[17300161] |
Experimental Toxicity
| Experiment Model | Experiment Organism | Toxicity Type | Toxicity Relation | Toxicity Value | Toxicity Unit | Reference |
|---|---|---|---|---|---|---|
| - | Homo sapiens | DILI_severity_class | = | 4.0 | n.a. | PMID[26948801] |
Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria
| Hepatotoxicity | Carcinogenicity | Mutagenicity | Cardiotoxicity | Respiratory Toxicity | Eye Irritation | Endocrine Disruption |
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
☉ ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
☉ TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]
  Chemically structural similarityTop-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)
Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.
●  The left chart: Distribution of similarity level between NPC599840 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC599840 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).
| Similarity Score | Similarity Level | Drug ID | Developmental Stage |
|---|---|---|---|
| 1.0 | High Similarity | NPD226 | Phase 4 |
| 0.6061 | Remote Similarity | NPD225 | Approved |
| 0.6061 | Remote Similarity | NPD227 | Approved |
| 0.5526 | Remote Similarity | NPD9589 | Approved |
| 0.5526 | Remote Similarity | NPD9590 | Approved |
| 0.5349 | Remote Similarity | NPD1360 | Phase 4 |
  Bioactivity similaritySimilarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.
